NCT02708134 Quality of Pediatric Resuscitation in a Multicenter Collaborative
| NCT ID | NCT02708134 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Philadelphia |
| Condition | Cardiac Arrest |
| Study Type | OBSERVATIONAL |
| Enrollment | 7,000 participants |
| Start Date | 2016-05-02 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 7,000 participants in total. It began in 2016-05-02 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, observational, multi-center cohort study of pediatric cardiac arrests. The purpose of the study is to determine the association between chest compression mechanics (rate, depth, flow fraction, compression release) and patient outcomes. In addition, the investigators will determine the association of post cardiac arrest care with patient outcomes.
Eligibility Criteria
Inclusion Criteria: * Patient received chest compressions for at least 1 minute * Patient between gestational age ≥37 weeks and 18 years of age Exclusion Criteria: * Patient on veno-arterial extracorporeal membrane oxygenation (ECMO) therapy at beginning of CPR event
Contact & Investigator
Vinay Nadkarni, MD, MS
PRINCIPAL INVESTIGATOR
Children's Hospital of Philadelphia
Frequently Asked Questions
Who can join the NCT02708134 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 18 Years, studying Cardiac Arrest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02708134 currently recruiting?
Yes, NCT02708134 is actively recruiting participants. Contact the research team at nadkarni@chop.edu for enrollment information.
Where is the NCT02708134 trial being conducted?
This trial is being conducted at Los Angeles, United States, Los Angeles, United States, Madera, United States, Orange, United States and 11 additional locations.
Who is sponsoring the NCT02708134 clinical trial?
NCT02708134 is sponsored by Children's Hospital of Philadelphia. The principal investigator is Vinay Nadkarni, MD, MS at Children's Hospital of Philadelphia. The trial plans to enroll 7,000 participants.